Lymphocytopenia in lupus erythematosus: Close in vivo association to autoantibodies targeting nuclear antigens

British Journal of Dermatology

Volumn 150, Issue 5, 2004, Pages 994-998

  Wenzel, J ^a   Gerdsen, R ^a   Uerlich, M ^a   Bauer, R ^a   Tueting, T ^a   Bieber, T ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Autoantibodies; Autoimmunity; Human; Lupus; T lymphocytes

Indexed keywords

AUTOANTIBODY; CELL NUCLEUS ANTIGEN; ANTINUCLEAR ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CELL SUBPOPULATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IN VIVO STUDY; LEUKOCYTE; LUPUS ERYTHEMATOSUS; LYMPHOCYTOPENIA; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PATIENT; PRIORITY JOURNAL; BLOOD; IMMUNOLOGY; LEUKOCYTE COUNT; MIDDLE AGED; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTINUCLEAR; ANTIGENS, NUCLEAR; FEMALE; HUMANS; LEUKOCYTE COUNT; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOPENIA; MALE; MIDDLE AGED;

EID: 3042739739     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05848.x     Document Type: Article

References (22)

1. Wenzel J, Bauer R, Bieber T et al. Discoid and subacute cutaneous lupus erythematosus: detection of differences in peripheral lymphocyte numbers. Acta Derm Venereol 2000; 80: 456.
2. von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum 1995; 24: 323-58.
3. Tan EM, Cohen AS, Fries JF. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-7.
4. Wenzel J, Gerdsen R, Uerlich M et al. Antibodies targeting extractable nuclear antigens: historical development and current knowledge. Br J Dermatol 2001; 145: 859-67.
5. Bermas BL, Petri M, Goldman D et al. T helper cell dysfunction in systemic lupus erythematosus (SLE): relation to disease activity. J Clin Immunol 1994; 14: 169-77.
6. Rivero SJ, Diaz-Jouanen E, Alarcon-Segovia D. Lymphopenia in systemic lupus erythematosus. Clinical, diagnostic, and prognostic significance. Arthritis Rheum 1978; 21: 295-305.
7. Wenzel J, Bauer R, Uerlich M et al. The value of lymphocytopenia as a marker of systemic involvement in cutaneous lupus erythematosus. Br J Dermatol 2002; 146: 869-71.
8. Wenzel J, Bauer R, Bieber T et al. Presence of antinuclear antibodies in patients with lupus erythematosus is correlated with diminished T-helper cells. Br J Dermatol 2000; 143: 1100-1.
9. Winfield JB, Mimura T. Pathogenetic significance of antilymphocyte autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 1992; 63: 13-16.
10. Coutinho A, Kazatchkine MD, Avrameas S. Natural autoantibodies. Curr Opin Immunol 1995; 7: 812-18.
11. Miranda ME, Tseng CE, Rashbaum W et al. Accessibility of SSA/Ro and SSB/La antigens to maternal autoantibodies in apoptotic human fetal cardiac myocytes. J Immunol 1998; 161: 5061-9.
12. Herrera-Esparza R, Guzman-Enriquez L, Avalos-Diaz E. Fate of human IgG from lupus erythematosus antinuclear antibody positive sera passively transfered to mice. Rev Rhum Engl Ed 1996; 63: 111-18.
13. Silva LM, Garcia AB, Donadi EA. Increased lymphocyte death by neglect - apoptosis is associated with lymphopenia and autoantibodies in lupus patients presenting with neuropsychiatric manifestations. J Neurol 2002; 249: 1048-54.
14. Kramer A. The structure and function of proteins involved in mammalian pre-mRNA splicing. Annu Rev Biochem 1996; 65: 367-409.
15. Stark H, Dube P, Luhrmann R, Kastner B. Arrangement of RNA and proteins in the spliceosomal U1 small nuclear ribonucleoprotein particle. Nature 2001; 409: 539-42.
16. Ma J, King N, Chen SL et al. Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization. Clin Exp Immunol 1993; 93: 396-404.
17. Reichlin M. Cell injury mediated by autoantibodies to intracellular antigens. Clin Immunol Immunopathol 1995; 76: 215-19.
18. Stafford HA, Chen AE, Anderson CJ et al. Anti-ribosomal and 'P-peptide'-specific autoantibodies bind to T lymphocytes. Clin Exp Immunol 1997; 109: 12-19.
19. Alarcon-Segovia D, Llorente L, Ruiz-Arguelles A. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage. J Autoimmun 1996; 9: 295-300.
20. Williams RC Jr, Peen E. Apoptosis and cell penetration by autoantibody may represent linked processes. Clin Exp Rheumatol 1999; 17: 643-7.
21. Ruiz-Arguelles A, Alarcon-Segovia D. Novel facts about an old marker: the LE cell. Scand J Clin Lab Invest Suppl 2001; 235: 31-7.
22. Vaishnaw AK, Toubi E, Ohsako S et al. The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations. Arthritis Rheum 1999; 42: 1833-42.